Journey Medical Balance Sheet Health
Financial Health criteria checks 3/6
Journey Medical has a total shareholder equity of $10.9M and total debt of $21.0M, which brings its debt-to-equity ratio to 192.5%. Its total assets and total liabilities are $64.0M and $53.1M respectively.
Key information
192.5%
Debt to equity ratio
US$21.04m
Debt
| Interest coverage ratio | n/a |
| Cash | US$22.46m |
| Equity | US$10.93m |
| Total liabilities | US$53.12m |
| Total assets | US$64.04m |
Recent financial health updates
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden
Sep 14
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?
May 06Recent updates
Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth
Oct 03Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden
Sep 14Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?
May 06Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%
Mar 11Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues
Jan 18Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Nov 10US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results
May 12Financial Position Analysis
Short Term Liabilities: DERM's short term assets ($46.2M) exceed its short term liabilities ($33.3M).
Long Term Liabilities: DERM's short term assets ($46.2M) exceed its long term liabilities ($19.8M).
Debt to Equity History and Analysis
Debt Level: DERM has more cash than its total debt.
Reducing Debt: Insufficient data to determine if DERM's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DERM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: DERM has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.9% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 16:18 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Journey Medical Corporation is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Scott Henry | Alliance Global Partners |
| Kalpit Patel | B. Riley Securities, Inc. |
| Brandon Folkes | Cantor Fitzgerald & Co. |